Home532296 • BOM
add
Glenmark Pharmaceuticals Ltd
Nakaraang pagsara
₹1,770.00
Sakop ng araw
₹1,760.50 - ₹1,785.00
Sakop ng taon
₹1,248.30 - ₹1,830.05
Market cap
503.78B INR
Average na Volume
39.71K
P/E ratio
48.09
Dividend yield
-
Primary exchange
NSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(INR) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Kita | 32.68B | -16.11% |
Gastos sa pagpapatakbo | 17.31B | 11.79% |
Net na kita | 46.50M | 100.38% |
Net profit margin | 0.14 | 100.45% |
Kita sa bawat share | 7.21 | 125.58% |
EBITDA | 5.69B | -55.59% |
Aktuwal na % ng binabayarang buwis | 45.02% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(INR) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 17.05B | 2.47% |
Kabuuang asset | 160.50B | 11.78% |
Kabuuang sagutin | 72.00B | 10.59% |
Kabuuang equity | 88.49B | — |
Natitirang share | 290.62M | — |
Presyo para makapag-book | 5.81 | — |
Return on assets | — | — |
Return on capital | 10.38% | — |
Cash Flow
Net change in cash
(INR) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Net na kita | 46.50M | 100.38% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Wikipedia
Itinatag
Nob 18, 1977
Website
Mga Empleyado
14,989